Yayın:
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorYakup Ergün
dc.contributor.authorCihan Erol
dc.contributor.authorRukiye Arıkan
dc.contributor.authorMuhammed Muhiddin Er
dc.contributor.authorMuhammed Mustafa Atçı
dc.contributor.authorAtakan Topçu
dc.contributor.authorGökhan Uçar
dc.contributor.authorBaran Akagündüz
dc.contributor.authorMusa Barış Aykan
dc.contributor.authorMiraç Özen
dc.contributor.authorNaziyet Köse Baytemür
dc.contributor.authorMelike Özçelik
dc.contributor.authorElif Şahin
dc.contributor.authorDeniz Can Güven
dc.contributor.authorSerkan Menekşe
dc.contributor.authorNaziye Ak
dc.contributor.authorFatih Teker
dc.contributor.authorEngin Kut
dc.contributor.authorTeoman Şakalar
dc.contributor.authorÖzkan Alan
dc.contributor.authorTurgut Kaçan
dc.contributor.authorN. S. Turhal
dc.contributor.authorSaadettin Kılıçkap
dc.contributor.authorSema Türker
dc.contributor.authorMehmet Alı Nahıt Şendur
dc.contributor.authorOsman Köstek
dc.contributor.authorMustafa Karaağaç
dc.contributor.authorAbdullah Sakin
dc.contributor.authorHacı Mehmet Türk
dc.contributor.authorDilek Çağlayan
dc.contributor.authorŞener Cihan
dc.contributor.authorYusuf Açıkgöz
dc.contributor.authorDoğan Uncu
dc.contributor.orcid0000-0002-3426-9505
dc.contributor.orcid0000-0003-4784-6743
dc.contributor.orcid0000-0003-3155-8798
dc.contributor.orcid0000-0003-2688-1515
dc.contributor.orcid0000-0002-0583-0295
dc.contributor.orcid0000-0002-1300-3695
dc.contributor.orcid0000-0002-3634-4820
dc.contributor.orcid0000-0002-7649-1075
dc.contributor.orcid0000-0002-4979-3123
dc.contributor.orcid0000-0001-7538-9119
dc.contributor.orcid0000-0002-1934-0190
dc.contributor.orcid0000-0002-3587-2517
dc.contributor.orcid0000-0003-0406-715X
dc.contributor.orcid0000-0002-1976-3951
dc.contributor.orcid0000-0002-6924-9467
dc.contributor.orcid0000-0002-2134-2128
dc.contributor.orcid0000-0001-5790-7066
dc.contributor.orcid0000-0003-4693-6587
dc.contributor.orcid0000-0002-5328-5607
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0002-6635-2012
dc.contributor.orcid0000-0002-2067-1560
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0003-1637-7390
dc.contributor.orcid0000-0001-9040-7266
dc.contributor.orcid0000-0001-7021-6139
dc.contributor.orcid0000-0002-1901-5603
dc.contributor.orcid0000-0003-4533-0620
dc.contributor.orcid0000-0003-2538-8569
dc.contributor.orcid0000-0003-2206-8148
dc.contributor.orcid0000-0003-4629-6815
dc.contributor.orcid0000-0002-3960-4982
dc.contributor.orcid0000-0002-0360-7938
dc.contributor.orcid0000-0002-0929-3271
dc.date.accessioned2025-11-13T19:39:28Z
dc.date.issued2022-04-17
dc.identifier.doihttps://doi.org/10.17305/bjbms.2021.7069
dc.identifier.endpage825
dc.identifier.issn1512-8601
dc.identifier.issue5
dc.identifier.openalexW4224023916
dc.identifier.startpage818
dc.identifier.urihttps://hdl.handle.net/11421/11478
dc.identifier.urihttps://doi.org/10.17305/bjbms.2021.7069
dc.identifier.volume22
dc.language.isoen
dc.relation.ispartofBosnian Journal of Basic Medical Sciences
dc.rightsopenAccess
dc.subjectTrastuzumab
dc.subjectMedicine
dc.subjectOxaliplatin
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectCisplatin
dc.subjectChemotherapy
dc.subjectFluorouracil
dc.subjectCancer
dc.subjectColorectal cancer
dc.subjectBreast cancer
dc.subject.sdg3
dc.titleFirst-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications